Study confirms vape dangers for vision
A large-scale US review has revealed an increased risk of visual impairment among users of e-cigarettes (vapers).
Staff reporters1 min read
Ophthalmology News
Guide dog Covid woes
The impact of Covid-19, exacerbated by a spike in kennel cough, has caused a significant drop in the number of guide dogs trained and matched to clients in 2021, reported Blind Low Vision New Zealand (BLVNZ).
Susanne Bradley3 min read
New free-form spectacle lens unveiled
US-based digital lens design company QLDS has developed Omnilux, a novel, natural accommodation multifocal spectacle lens the company says requires no fitting-height measurement or adaptation period.
Staff reporters3 min read
Covid spikes mucormycosis cases
US researchers have formally linked Covid-19 infection with a recent surge in mucormycosis, also known as ‘black fungus’ and formerly considered a rare disease. Led by ophthalmologist Dr Andrea
Staff reporters1 min read
Frequent glaucoma reviews more effective, cost less
An Australian and US study has found that, compared to in-depth annual reviews, less stringent six-monthly reviews of glaucoma suspects resulted in more diagnoses, fewer overall clinical visits and
Staff reporters2 min read
Two-year stem-cell AMD implant
A US trial has shown a bioengineered stem-cell-derived retinal implant produced donor cells two years after implantation in a patient with advanced dry age-related macular degeneration (AMD), despite
Staff reporters2 min read
New artificial vision system implanted
A first-of-its-kind artificial vision system has successfully been implanted, providing the possibility of restoring partial vision to people with sight loss due to eye disease or trauma. The
Staff reporters2 min read
IVT injections unnecessary in a third of nAMD patients
A Johns Hopkins Medicine study of 106 patients with wet (neovascular) age-related macular degeneration (nAMD) has found a third of patients could cease intravitreal (IVT) injections without further vision loss.
Staff reporters2 min read
DED cream – trial begins
Glaukos has enrolled its first patient for its phase 2 trials of GLK-301, a pilocarpine-based cream applied to the outer eyelid to treat dry eye disease (DED). The California-based ophthalmic
Staff reporters1 min read
Keratoplasty rejection after Covid vaccination
US researchers have reported four cases or corneal transplant rejection in patients following their Covid-19 vaccinations.
Staff reporters1 min read
Type-2 kids’ higher DR risk
A US study of diabetic children, published in Jama Ophthalmology, has found that those with type-2 diabetes (T2D) had nearly double the risk of developing retinopathy compared to those with type-1 (T1D). Further, authors noted pars plana vitrectomy occurred within a shorter diabetes duration for T2D
Staff reporters1 min read
FDA fast-tracks Australian bionic eye
An Australian-developed bionic eye for retinitis pigmentosa (RP) patients has been granted ‘breakthrough’ designation by the US Food and Drug Administration (FDA), fast tracking its review process.
Staff reporters1 min read